REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 57 filers reported holding REPROS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | – | 400 | +166.7% | 0.00% | – |
| Q3 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 150 | -84.6% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 975 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -93.8% | 975 | -54.4% | 0.00% | – |
| Q3 2015 | $16,000 | +100.0% | 2,140 | +86.1% | 0.00% | – |
| Q2 2015 | $8,000 | -20.0% | 1,150 | 0.0% | 0.00% | – |
| Q1 2015 | $10,000 | -9.1% | 1,150 | 0.0% | 0.00% | – |
| Q4 2014 | $11,000 | -35.3% | 1,150 | -33.9% | 0.00% | – |
| Q3 2014 | $17,000 | +142.9% | 1,740 | +335.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
| Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
| Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
| Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
| Renaissance Technologies | 716,413 | $946,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
| Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |